IntroductionMolecular chirality plays a very important role in science and technology. For example, the biological activity of many pharmaceuticals and agrochemicals is often associated with a single enantiomer. The increasing demand for enantiomerically pure pharmaceuticals, agrochemicals, and fine chemicals has therefore driven the development of asymmetric catalytic technologies [1, 2]. Asymmetric hydrogenation, using molecular hydrogen to reduce prochiral olefins, ketones, and imines, has become one of the most efficient, practical, and atom-economical methods for the construction of chiral compounds [3]. During the last few decades of the 20th century, significant attention was devoted to the discovery of new asymmetric catalysts, in which transition metals bound to chiral phosphorous ligands have emerged as preferential catalysts for asymmetric hydrogenation. Thousands of efficient chiral phosphorous ligands with diverse structures have been developed, and their application to asymmetric hydrogenation has been established. Indeed, many represent the key step in industrial processes for the preparation of enantiomerically pure compounds. The immense significance of asymmetric hydrogenation was recognized when the Nobel Prize in Chemistry was awarded to Knowles and Noyori.In this chapter, we focus on the rhodium-catalyzed hydrogenation and the development of chiral phosphorous ligands for this process. Although there are other chiral phosphorous ligands, which are effective for ruthenium-, iridium-, platinum-, titanium-, zirconium-, and palladium-catalyzed hydrogenation, they are not discussed in this account. However, this does not preclude complexes of other transition metals as effective catalysts for asymmetric hydrogenation. Fortunately, there are numerous reviews and books that discuss this particular aspect of asymmetric hydrogenation [3].
Chiral Phosphorous LigandsThe invention of efficient chiral phosphorous ligands has played a critical role in the development of asymmetric hydrogenation. To a certain extent, the development of asymmetric hydrogenation parallels that of chiral phosphorous ligands.
The introduction of Wilkinson's homogeneous hydrogenation catalyst, [RhCl(PPh 3 ) 3 ][4], prompted the development of the analogous asymmetric hydrogenation by Knowles [5] and Horner [6] using chiral monodentate phosphine ligands, albeit with poor enantioselectivity. Kagan and Knowles each demonstrated that improved enantioselectivities could be obtained using bidentate chiral phosphine ligands. For example, Kagan and Knowles independently reported the C 2 -symmetric bisphosphine ligands, DIOP [7] and DIPAMP [8], for rhodium-catalyzed asymmetric hydrogenation. Due to its high catalytic efficiency in rhodium-catalyzed asymmetric hydrogenation of dehydroamino acids, DIPAMP was employed in the industrial production of l-DOPA [9]. Subsequently to this work, several other successful chiral phosphorous ligands were developed, as exemplified by Kumada's ferrocene ligand BPPFOH [10] and Achiwa's BPPM ligand [11]....